Robert J. DelAversano - 09 Feb 2023 Form 4 Insider Report for ONCOSEC MEDICAL Inc

Reporting relationship: VP, Finance
Issuer ticker: N/A
Reported as of: 09 Feb 2023
Net transaction value: -$54.8
SEC form: 4
Accepted by SEC: 09 Feb 2023, 19:11:50 UTC
Prior SEC filing: 04 Nov 2022
Next SEC filing: 08 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Robert J. DelAversano

Key filing fact

Robert J. DelAversano filed Form 4 for ONCOSEC MEDICAL Inc on 09 Feb 2023.

Key facts

This page summarizes Robert J. DelAversano's Form 4 filing for ONCOSEC MEDICAL Inc.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Feb 2023, 19:11.

Change

Previous filing in this sequence was filed on 04 Nov 2022.
Current net transaction value: -$54.8.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONCS transaction

Common Stock

Sale

Transaction value: $54.8
Shares: -40
Change %: -3.8%
Price: $1.37
Shares after: 1,008
Date: 09 Feb 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

In connection with the vesting of 49 RSUs on February 1, 2023, a total of 40 shares were sold in order to satisfy the reporting person's tax withholding obligations. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.

Footnote F2

Effective as of 12:01 a.m. Eastern Time on November 9, 2022, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-22.